The contribution of hypoxia to the association between sleep apnoea,insomnia,and cardiovascular mortality in community-dwelling elderly with and without cardiovascular disease

Abstract

Aims:

This study explores if nightly hypoxia (i.e. percentage of sleep time with oxygen saturation lower than 90% (SaO₂<90%)) contributed to the association between sleep-disordered breathing (SDB) and insomnia in community-dwelling elderly with and without cardiovascular disease (CVD). A second aim was to explore a potential cut-off score for hypoxia to predict insomnia and the association of the cut-off with clinical characteristics and cardiovascular mortality.

Method:

A total of 331 community-dwelling elderly aged 71–87 years underwent one-night polygraphic recordings. The presence of insomnia was recorded by a self-report questionnaire. The presence of CVD was objectively established and mortality data were collected after three and six years.

Results:

In both patients with CVD (n=119) or without CVD (n=212) SDB was associated with hypoxia (p<0.005). Only in the patients with CVD was hypoxia associated with insomnia (p<0.001) which mediated an indirect effect (p<0.05) between SDB and insomnia. Hypoxia of more than 1.5% of sleep time with SaO₂<90% was found to be a critical level for causing insomnia. According to this criterion 32% (n=39) and 26% (n=55) of those with and without CVD had hypoxia, respectively. These groups did not differ with respect to age, gender, body mass index, diabetes, hypertension, respiratory disease or levels of SDB. However, in the CVD group, hypoxia was associated with cardiovascular mortality at the three-year follow-up (p=0.008) and higher levels of insomnia (p=0.002).

Conclusion:

In the elderly with CVD, SDB mediated by hypoxia can be associated with more insomnia and a worse prognosis.

Keywords

Elderly cardiovascular disease sleep-disordered breathing hypoxia insomnia

Get full access to this article

View all access options for this article.

References

Johansson

Alehagen

Svanborg

. Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness. Sleep Med 2009; 10: 1005–1011.

Shahar

Whitney

Redline

. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19–25.

Bjornnsdottir

Janson

Gíslason

. Insomnia in untreated sleep apnea patients compared to controls. J Sleep Res 2012; 21: 131–138.

Smith

Sullivan

Hopkins

. Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS). Sleep Med 2004; 5: 449–456.

Johansson

Arestedt

Alehagen

. Sleep disordered breathing, insomnia, and health related quality of life – a comparison between age and gender matched elderly with heart failure or without cardiovascular disease. Eur J Cardiovasc Nurs 2010; 9: 108–117.

Gooneratne

Gehrman

Nkwuo

. Consequences of comorbid insomnia symptoms and sleep-related breathing disorder in elderly subjects. Arch Intern Med 2006; 166: 1732–1738.

Bixler

Vgontzas

Ten Have

. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med 1998; 157: 144–148.

Bradley

Floras

. Sleep apnea and heart failure: Part II: Central sleep apnea. Circulation 2003; 107: 1822–1826.

Bradley

Floras

. Sleep apnea and heart failure: Part I: Obstructive sleep apnea. Circulation 2003; 107: 1671–1678.

10.

Phillips

. Sleep-disordered breathing and cardiovascular disease. Sleep Med Rev 2005; 9: 131–140.

11.

Gottlieb

Schwartz

Marshall

. Hypoxia, not the frequency of sleep apnea, induces acute hemodynamic stress in patients with chronic heart failure. J Am Coll Cardiol 2009; 54: 1706–1712.

12.

Redeker

Muench

Zucker

. Sleep disordered breathing, daytime symptoms, and functional performance in stable heart failure. Sleep 2010; 33: 551–560.

13.

Ferrier

Campbell

Yee

. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005; 128: 2116–2122.

14.

Rao

Georgiadou

Francis

. Sleep-disordered breathing in a general heart failure population: Relationships to neurohumoral activation and subjective symptoms. J Sleep Res 2006; 15: 81–8.

15.

Alehagen

Goetze

Dahlstrom

. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (NT-proBNP) in the elderly. Clin Chim Acta 2007; 382: 8–14.

16.

Flemons

Littner

Rowley

. Home diagnosis of sleep apnea: A systematic review of the literature. An evidence review cosponsored by the American Academy of Sleep Medicine, the American College of Chest Physicians, and the American Thoracic Society. Chest 2003; 124: 1543–1579.

17.

Douglas

. Home diagnosis of the obstructive sleep apnoea/hypopnoea syndrome. Sleep Med Rev 2003; 7: 53–59.

18.

American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22: 667–689.

19.

Liljenberg

Almqvist

Hetta

. The prevalence of insomnia: The importance of operationally defined criteria. Ann Clin Res 1988; 20: 393–398.

20.

Mallon

Hetta

. A survey of sleep habits and sleeping difficulties in an elderly Swedish population. Ups J Med Sci 1997; 102: 185–197.

21.

Mallon

Broman

Hetta

. Sleep complaints predict coronary artery disease mortality in males: A 12-year follow-up study of a middle-aged Swedish population. J Intern Med 2002; 251: 207–216.

22.

Brostrom

Stromberg

Dahlstrom

. Sleep difficulties, daytime sleepiness, and health-related quality of life in patients with chronic heart failure. J Cardiovasc Nurs 2004; 19: 234–242.

23.

Hair

Andersson

Tatham

. Multivariate data analysis. New Jersey: Prentice Hall, 1998.

24.

Bonsignore

Esquinas

Barceló

. Metabolic syndrome, insulin resistance and sleepiness in real-life obstructive sleep apnoea. Eur Respir J 2012; 39: 1136–1143.

25.

Assoumou

H-G

Gaspoz

J-M

Sforza

. Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: The SYNAPSE cohort. Sleep Breath 2012; 16: 895–902.

26.

Duran

Esnaola

Rubio

. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med 2001; 163: 685–689.

27.

Martinez-Garcia

Soler-Cataluna

Roman-Sanchez

. Obstructive sleep apnea has little impact on quality of life in the elderly. Sleep Med 2009; 10: 104–111.

28.

Johansson

Alehagen

Svensson

. Determinants of global perceived health in community-dwelling elderly screened for heart failure and sleep-disordered breathing. J Cardiovasc Nurs 2010; 25: E16–E26.

29.

Dodt

Breckling

Derad

. Plasma epinephrine and norepinephrine concentrations of healthy humans associated with nighttime sleep and morning arousal. Hypertension 1997; 30: 71–76.

30.

Bonnet

Arand

. Heart rate variability: Sleep stage, time of night, and arousal influences. Electroencephalogr Clin Neurophysiol 1997; 102: 390–396.

31.

Beneto

Gomez-Siurana

Rubio-Sanchez

. Comorbidity between sleep apnea and insomnia. Sleep Med Rev 2009; 13: 287–293.

32.

Levy

Pepin

Arnaud

. Intermittent hypoxia and sleep-disordered breathing: Current concepts and perspectives. Eur Respir J 2008; 32: 1082–1095.

33.

Gilmartin

Lynch

Tamisier

. Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2010; 299: H925–H931.

34.

Prabhakar

Kumar

Peng

. Sympatho-adrenal activation by chronic intermittent hypoxia. J Appl Physiol 2012; 113: 1304–1310.

35.

Frohnhofen

Roffe

. Intermittent nocturnal hypoxemia in individuals with dementia: Prevalence and relationship with functional status. J Am Geriatr Soc 2012; 60: 1997–1999.

36.

Bonnet

Arand

. Hyperarousal and insomnia: State of the science. Sleep Med Rev 2010; 14: 9–15.

37.

Yamout

Goldstein

Lah

. Neurocognitive correlates of nocturnal oxygen desaturation in a memory clinic population. J Clin Exp Neuropsychol 2012; 34: 325–332.

38.

Esler

Kaye

. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease. J Cardiovasc Pharmacol 2000; 35: S1–S7.

39.

Goldman

Reeder

Muir

. Repetitive nocturnal arterial oxygen desaturation and silent myocardial ischemia in patients presenting for vascular surgery. J Am Geriatr Soc 1993; 41: 703–709.

40.

Semenza

Prabhakar

. HIF-1-dependent respiratory, cardiovascular, and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal 2007; 9: 1391–1396.

41.

Garvey

Taylor

McNicholas

. Cardiovascular disease in obstructive sleep apnoea syndrome: The role of intermittent hypoxia and inflammation. Eur Respir J 2009; 33: 1195–1205.

42.

Johansson

Riegel

Svensson

. Sickness behavior in community-dwelling elderly associations with impaired cardiac function and inflammation. Biol Res Nurs 2014; 16: 105–113.

43.

Anderson

Berk

Maes

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome. Acta Psychiatr Scand 2014; 126: 83–97.

44.

Von Kanel

Dimsdale

Ancoli-Israel

. Poor sleep is associated with higher plasma proinflammatory cytokine interleukin-6 and procoagulant marker fibrin D-dimer in older caregivers of people with Alzheimer’s disease. J Am Geriatr Soc 2006; 54: 431–437.

45.

Dantzer

O’Connor

Freund

. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46–56.

46.

Yousuf

Mohanty

Martin

. High-sensitivity C-reactive protein and cardiovascular disease: A resolute belief or an elusive link? J Am Coll Cardiol 2013; 62: 397–408.

47.

Hunt

Walsh

Voegeli

. Inflammation in aging part 1: Physiology and immunological mechanisms. Biol Res Nurs 2010; 11: 245–252.

48.

Ensrud

Blackwell

Ancoli-Israel

. Sleep disturbances and risk of frailty and mortality in older men. Sleep Med 2012; 13: 1217–1225.

49.

Lavie

. Molecular mechanisms of cardiovascular disease in OSAHS: The oxidative stress link. Eur Respir J 2009; 33: 1467–1484.

50.

Anand

Latini

Florea

. C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation 2005; 112: 1428–1434.